Evidence map›Paper›PMID 40768676›Full record

ArticleJCO precision oncology2025

Multi-Regional Profiling of Epidermal Growth Factor Receptor L858R Mutation-Positive Metastatic Renal Pelvic Cancer Successfully Treated With Osimertinib.

Yoshiyuki Yamamoto, Atsushi Kuwahara, Atsunari Kawashima, Daisuke Motooka, Yoshitake Iwamoto, Takehiro Yamamoto, Masako Kurashige, Daisuke Sakai, Yuki Horibe, Yu Ishizuya and 8 more

Abstract read
In one paragraph

Article in JCO precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yoshiyuki YamamotoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-1271-3521
Atsushi KuwaharaNGS Core Facility, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.
Atsunari KawashimaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-9369-4264
Daisuke MotookaNGS Core Facility, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.ORCID 0000-0002-4616-9608
Yoshitake IwamotoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0009-0007-2540-8810
Takehiro YamamotoDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Masako KurashigeDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Daisuke SakaiCenter for Cancer Genomics and Precision Medicine, Osaka University Hospital, Suita, Japan.ORCID 0000-0002-9436-7553
Yuki HoribeDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Yu IshizuyaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Takuji HayashiDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0003-2030-3087
Kentaro TakezawaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Taigo KatoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-8681-1407
Koji HatanoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-8409-5152
Yoichi KakutaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-5339-4312
Taroh SatohCenter for Cancer Genomics and Precision Medicine, Osaka University Hospital, Suita, Japan.ORCID 0000-0002-4615-2638
Eiichi MoriiDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-8490-3650
Norio NonomuraDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40768676
PMCPMC12337946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.